GFAP and Alzheimer disease: Reactive astrocytes have been linked to neuroinflammation in AD patients that precedes Aβ plaques, with clinical studies showing a significant increase in peripheral blood GFAP levels in dementia patients compared to healthy controls (Kim et al., 2023).